Influenza is a seasonal acute respiratory infection, causing millions of illnesses worldwide on a yearly basis. A common subtype, the influenza A virus (IAV), is a single stranded RNA virus, that similarly to other subtypes, targets epithelial cells. The best way to protect against the virus is through vaccination. Vaccine induced protection is mediated through the generation of adaptive CD4 and CD8 T cells, as well as antibody producing B Cells. Although generally thought of as helper cells, previous research has highlighted additional roles of memory CD4 T cells in mediating protection against IAV beyond their helper function. More specifically they have been shown to enhance innate inflammatory responses and facilitate the recruitment of...
Persistent and durable immunological memory forms the basis of any successful vaccination protocol. ...
Upon infection, naive T cells proliferate and differentiate into highly specialized effector cells t...
An attractive strategy to improve efficacy of current Influenza A Virus (IAV) vaccines is to promote...
There is continued interest in developing novel vaccine strategies that induce establish optimal CD8...
Memory regulatory T cells (mTregs) have been demonstrated to persist long-term in hosts after the re...
Memory regulatory T cells (mTregs) have been demonstrated to persist long-term in hosts after the re...
Innate lymphoid cells (ILCs) are recently discovered group of innate immune cells. They do not have ...
Vaccination is the most effective way to prevent disease associated with influenza infection. Howeve...
Influenza viral evolution presents a formidable challenge to vaccination due to the virus\u27 abilit...
The contributions of peptide antigen affinity for TCR in driving T cell memory is unclear. Effector ...
Protective lung tissue-resident memory CD8+T cells (Trm) form after influenza A virus (IAV) infectio...
Memory CD4 T cells specific for influenza virus are generated from natural infection and vaccination...
Protective immunity against influenza virus infection is believed to be mediated by neutralising ant...
SummaryTissue-resident memory T (Trm) cells provide enhanced protection against infection at mucosal...
Recent observations have uncovered multiple pathways whereby CD4 T cells can contribute to protectiv...
Persistent and durable immunological memory forms the basis of any successful vaccination protocol. ...
Upon infection, naive T cells proliferate and differentiate into highly specialized effector cells t...
An attractive strategy to improve efficacy of current Influenza A Virus (IAV) vaccines is to promote...
There is continued interest in developing novel vaccine strategies that induce establish optimal CD8...
Memory regulatory T cells (mTregs) have been demonstrated to persist long-term in hosts after the re...
Memory regulatory T cells (mTregs) have been demonstrated to persist long-term in hosts after the re...
Innate lymphoid cells (ILCs) are recently discovered group of innate immune cells. They do not have ...
Vaccination is the most effective way to prevent disease associated with influenza infection. Howeve...
Influenza viral evolution presents a formidable challenge to vaccination due to the virus\u27 abilit...
The contributions of peptide antigen affinity for TCR in driving T cell memory is unclear. Effector ...
Protective lung tissue-resident memory CD8+T cells (Trm) form after influenza A virus (IAV) infectio...
Memory CD4 T cells specific for influenza virus are generated from natural infection and vaccination...
Protective immunity against influenza virus infection is believed to be mediated by neutralising ant...
SummaryTissue-resident memory T (Trm) cells provide enhanced protection against infection at mucosal...
Recent observations have uncovered multiple pathways whereby CD4 T cells can contribute to protectiv...
Persistent and durable immunological memory forms the basis of any successful vaccination protocol. ...
Upon infection, naive T cells proliferate and differentiate into highly specialized effector cells t...
An attractive strategy to improve efficacy of current Influenza A Virus (IAV) vaccines is to promote...